Original Research
Published on 27 Feb 2024
Serum EZH2 is a novel biomarker for bladder cancer diagnosis and prognosis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1303918
- 1,268 views
- 2 citations
Type at least 3 characters
1,560 articles
Articles
Original Research
Published on 27 Feb 2024
Deep learning-based radiomics model from pretreatment ADC to predict biochemical recurrence in advanced prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1342104
- 1,226 views
Original Research
Published on 26 Feb 2024
Predictive value of volumetric parameters based on 18F-PSMA-1007 PET/CT for prostate cancer metastasis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1335205
- 970 views
Original Research
Published on 21 Feb 2024
BioPrev-C – development and validation of a contemporary prostate cancer risk calculator
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1343999
- 764 views
Original Research
Published on 21 Feb 2024
Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1202277
- 1,710 views
Original Research
Published on 21 Feb 2024
Predictive value of controlling nutritional status score for prostate cancer diagnosis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1268800
- 793 views
Original Research
Published on 20 Feb 2024
Lower baseline testosterone level is related to earlier development of castration resistance in metastatic prostate cancer: a multi-center cohort study
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1321522
- 1,247 views
- 1 citation
Case Report
Published on 15 Feb 2024
Case report: Enfortumab vedotin induced refractory DKA and multi organ failure – a rare fatal adverse event
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1332478
- 1,865 views
- 2 citations
Original Research
Published on 15 Feb 2024
Absence of GATA3/FOXA1 co-expression predicts poor prognosis in upper tract urothelial carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1302864
- 1,083 views
Case Report
Published on 12 Feb 2024
Case report: Ectopic corpus cavernosum presented as bladder tumor in a 3-year-old boy
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1308493
- 887 views
Original Research
Published on 12 Feb 2024
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1307635
- 1,635 views
Editorial
Published on 07 Feb 2024
Editorial: Circulating biomarkers in prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1365353
- 985 views
Case Report
Published on 02 Feb 2024
Acquired cystic disease-associated renal cell carcinoma with PTCH1 mutation: a case report
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1349610
- 1,265 views
Original Research
Published on 02 Feb 2024
Clinical efficacy analysis of partial cystectomy and radical cystectomy in the treatment of muscle-invasive sarcomatoid carcinoma of the urinary bladder
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1324487
- 954 views
- 1 citation
Original Research
Published on 01 Feb 2024
Retrospective study on the toxicity induced by stereotactic body radiotherapy: overview of the reunion experience on prostate cancer in elderly patients
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1302001
- 1,015 views
Original Research
Published on 31 Jan 2024
Clinical significance of serum high sensitive C-reactive protein/albumin ratio in primary prostate biopsy
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1325524
- 1,186 views
- 1 citation